Showing results (2141-2150 of 2,402) with videos related to
Sort By:
Pageof 241
Journal of General Internal Medicine|July 26, 2024
Receipt of Gender-Affirming Surgeries Among Transgender and Gender Diverse VeteransAlyson J Littman, Amy Jeon, Carolyn L Fort, et al.Frontiers in Artificial Intelligence|March 21, 2022
Developing a Cancer Digital Twin: Supervised Metastases Detection From Consecutive Structured Radiology ReportsKaren E Batch, Jianwei Yue, Alex Darcovich, et al.Experimental Dermatology|May 18, 2021
Insights into adult atopic dermatitis heterogeneity derived from circulating biomarker profiling in patients with moderate-to-severe diseaseJonathan T Sims, Ching-Yun Chang, Richard E Higgs, et al.Journal of the American Academy of Dermatology|May 18, 2025
Skin clearance, duration of treatment-free interval, and safety of tapinarof cream 1% once daily: Results from ADORING 3, a 48-week phase 3 open-label extension trial in adults and children down to 2 years of age with atopic dermatitisRobert Bissonnette, Linda Stein Gold, Leon Kircik, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 9, 2025
Circulating Tumor Cells Shed Shearosome Extracellular Vesicles in Capillary Bifurcations That Activate Endothelial and Immune CellsAngelos Vrynas, Salime Bazban-Shotorbani, Sara Arfan, et al.Genes|January 21, 2017
Familial Lung Cancer: A Brief History from the Earliest Work to the Most Recent StudiesAnthony M Musolf, Claire L Simpson, Mariza de Andrade, et al.Abdominal Radiology (New York)|June 29, 2019
Radiomics-based prediction of microsatellite instability in colorectal cancer at initial computed tomography evaluationJennifer S Golia Pernicka, Johan Gagniere, Jayasree Chakraborty, et al.Dermatology and Therapy|June 23, 2025
Two-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)Emma Guttman-Yassky, Stephan Weidinger, Eric L Simpson, et al.Gerontology & Geriatrics Education|May 17, 2025
Interprofessional geriatric education in a post-pandemic world: comparing outcomes of in-person versus virtual simulationsDiane Brown, Cynthia Hovland, Susan Hazelett, et al.The British Journal of Dermatology|February 22, 2019
Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a pooled analysis of data from two phase III trialsJ I Silverberg, E L Simpson, M Ardeleanu, et al.Pageof 241